Evidence map›Paper›PMID 29844698›Full record

ArticleInternational journal of general medicine2018

Exploring factors that might influence primary-care provider discussion of and recommendation for prostate and colon cancer screening.

Christine E Kistler, Maihan Vu, Anne Sutkowi-Hemstreet, Ziya Gizlice, Russell P Harris, Noel T Brewer, Carmen L Lewis, Rowena J Dolor, Colleen Barclay, Stacey L Sheridan

Abstract read
In one paragraph

Article in International journal of general medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Christine E KistlerDepartment of Family Medicine, School of Medicine.
Maihan VuCenter for Health Promotion and Disease Prevention, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Anne Sutkowi-HemstreetNapa County Office of Education, Napa, CA.
Ziya GizliceBiostatistical Support Unit, Center for Health Promotion and Disease Prevention.
Russell P HarrisCecil G Sheps Center for Health Services Research.
Noel T BrewerDepartment of Health Behavior, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Carmen L LewisDivision of General Internal Medicine, Department of Medicine, University of Colorado School of Medicine, Aurora, CO.
Rowena J DolorDivision of General Internal Medicine, Duke University School of Medicine, Durham, NC.
Colleen BarclayCecil G Sheps Center for Health Services Research.
Stacey L SheridanReaching for High Value Care Team, Chapel Hill, NC, USA.

Funding

Understanding Physicians' and Patients' Views of Harms and Clinical Preventive SP01HS021133 · AHRQ · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HARRIS, RUSSELL P · 2011 to 2013
$4.5M
UNC Mentored Career Development Program in Comparative Effectiveness ResearchK12HS019468 · AHRQ · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WEINBERGER, MORRIS · 2010 to 2010
$2.0M
AHRQ HHS K12 HS019468AHRQ HHS P01 HS021133
6 · The paper itself

Abstract

backgroundPrimary-care providers may contribute to the use of low-value cancer screening.

objectiveWe sought to examine circumstances under which primary-care providers would discuss and recommend two types of cancer screening services across a spectrum of net benefit and other factors known to influence screening. PATIENTS AND

methodsThis was a cross sectional survey of 126 primary-care providers in 24 primary-care clinics in the US. Participants completed surveys with two hypothetical screening scenarios for prostate or colorectal cancer (CRC). Patients in the scenarios varied by age and screening-request status. For each scenario, providers indicated whether they would discuss and recommend screening. Providers also reported on their screening attitudes and the influence of other factors known to affect screening (short patient visits, worry about lawsuits, clinical reminders/performance measures, and screening guidelines). We examined associations between providers' attitudes and their screening recommendations for hypothetical 90-year-olds (the lowest-value screening).

resultsProviders reported they would discuss cancer screening more often than they would recommend it ( DISCUSSION: While most providers' reported practice patterns aligned with net benefit, some providers would discuss and recommend low-value cancer screening, particularly when faced with a patient request.

conclusionMore work appears to be needed to help providers to discuss and recommend screening that aligns with value.

Indexed as

cancer screeningcolon cancerdecision makinglow-value careolder adultsprostate cancer

Identifiers

PMID29844698
PMCPMC5962312

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.